HEADLINES
Jerusalem journalist detained over alleged Iran contact
Indonesia to join Gaza ISF Phase II
Netanyahu to discuss Iran with Trump
The time is now 4:01 PM in New York, I'm Noa Levi and this is the latest Israel Today: Ongoing War Report.
In the conflict with Iran and its Regional Proxies, a Jerusalem-based independent journalist who reported suspected Iranian recruitment was detained and questioned on suspicion of contact with a foreign agent after alerting police. The journalist, who cannot be named due to a gag order, says unidentified individuals contacted him via social media in January, asking him to photograph Jerusalem streets, including ultra-Orthodox demonstrations, which he believed could be recruitment by Iranian intelligence. He voluntarily contacted the Jerusalem Police’s cyber unit, but upon arriving to share information he was detained and questioned by the Shin Bet and police. He spent several days in detention while being interrogated on suspicion of contact with a foreign agent. In another development reflecting regional tensions tied to Iranian proxies, CENTCOM chief Brad Cooper praised the Lebanese army for uncovering a Hezbollah tunnel for the second time in two weeks; a new hospital opened in Beirut’s Dahieh with a speech by Hezbollah’s leader, a day after Kuwait blacklisted Lebanese hospitals over ties to the group.
In the Disputed Territories (Gaza, Judea and Samaria, East Jerusalem), Indonesia is expected to become the first country to contribute troops to Gaza’s International Stabilization Force during Phase II of the ceasefire, according to KAN News. Indonesia could have troops on the ground within weeks, following President Prabowo Subianto’s visit to Washington for the Peace to Prosperity summit on February 19. The ISF is not expected to seek direct confrontation with Hamas or to proactively disarm the group; instead, Indonesian forces would supervise ceasefire lines and possibly handle border-related duties, including defense lines in Khan Yunis and Rafah, within the framework of the Trump administration’s Phase II.
In US Policy Concerning Israel, Prime Minister Benjamin Netanyahu will travel to the United States for a strategy-shaping session with President Trump and senior aides to discuss the current US-Iran talks and options if diplomacy fails, including the possibility of a US military strike. Attendees include military secretary Major-General Roman Gofman and acting NSC director Gil Reich. US Vice President JD Vance said there are no redlines at this stage, but Trump seeks a broad and meaningful agreement, with Washington warning vessels flying the US flag to stay as far as possible from Iranian waters while transiting the Strait of Hormuz. Netanyahu then heads to Washington for a closed-door meeting with Trump to press for strict red lines over Iran’s nuclear program and ballistic missiles, even as regional allies push for a lighter deal.
In Antisemitism and Anti-Jewish Hate, an Australian advertisement opposing Herzog’s visit sparked backlash over false, unauthorized names and the inclusion of kapos. The ad reportedly lists names associated with Nazi camps, including three historical kapos, and appeared on World Israel News, drawing criticism for the false attribution and for invoking Nazi-era references in criticizing the visit.
In Israeli Domestic Politics, National Security Minister Itamar Ben-Gvir announced he would not approve the appointment or promotion of senior police officer Ruti Hauslich, citing a pattern of “grave misconduct” including impersonation of authority, misleading Knesset committees, and violations of police ordinances. The decision was formalized in a letter to Deputy Attorneys-General Gil Limon and Sharon Afek, responding to objections to his earlier refusal to advance Hauslich. Ben-Gvir grounded his stance in part on the Rinat Saban ruling handed down earlier that day as part of the wider context of senior police promotions. Hauslich had signed an official letter on September 10, 2025, identifying herself as acting head of the police’s Investigations and Intelligence Division—a role not yet appointed, with approval still under ministerial review.
In Israeli Economy and Business, Israel Aerospace Industries delivered the 350th fighter jet wing to Lockheed Martin for the F-35 program. This follows the January 18 arrival of three F-35i aircraft at Nevatim Air Force Base, raising Israel’s on-hand inventory to 48 of 50. The wings underscore IAI’s broader role in supporting the global F-35 fleet, now operated by about 1,300 jets across 11 countries. Defense Minister Katz indicated that the F-35s were pivotal for strikes against Iran’s nuclear program in 2025 and could be deployed again soon. Separately, Elbit Systems announced about $100 million in contracts with the Israeli Defense Ministry to develop next-generation digitization capabilities for the IDF, including the Digital Ground Army (Tzayad) and Multi-Sensor Border Defense System (MARS) programs. The initiative aims to deliver advanced command and control across air, sea, and land with full multi-domain connectivity and to enhance operational decision-making through artificial intelligence.
In Uplifting News, Israeli researchers from the Weizmann Institute of Science and Washington University in St. Louis report a world-first use of CAR T-cell therapy, originally developed to treat blood cancers, to combat brain inflammation in a mouse model of Alzheimer’s disease. The study, published in the Proceedings of the National Academy of Sciences and led by Prof. Ido Amit and Prof. Jonathan Kipnis, builds on foundational work by late Prof. Zelig Eshhar, noting that the approach could open pathways to treating Alzheimer's and other neurodegenerative disorders in the future.
Thank you for tuning in to this Israel Today: Ongoing War Report update.
I'm Noa Levi. Stay safe and informed.
Keep in mind that this AI-generated report may contain occasional inaccuracies, so consult multiple sources for a comprehensive view. Find the code and more details in the podcast description.
SOURCES
https://www.jpost.com/israel-news/article-886133
https://www.ynetnews.com/article/rj65qhvv11x
https://www.jpost.com/middle-east/article-886141
https://www.jpost.com/israel-news/article-886137
https://www.ynetnews.com/article/hk7jehwwzl
https://worldisraelnews.com/australian-ad-opposing-herzog-visit-sparks-backlash-over-false-unauthorized-names-and-inclusion-of-kapos/
https://www.jpost.com/israel-news/article-886135
https://www.jpost.com/defense-and-tech/article-886139
https://www.jpost.com/defense-and-tech/article-886132
https://www.timesofisrael.com/in-world-first-israeli-researchers-use-blood-cancer-treatment-for-alzheimers-in-mice/